Illumina/PacBio abandon merger
The Competition and Markets Authority (CMA) has therefore today confirmed that it will be cancelling its Phase 2 merger investigation. Illumina, Inc. (Illumina) and Pacific Biosciences of California, Inc (PacBio) are both global suppliers of Next-Gene… read more